Conclusion
There is an independent graded negative association between levels of eGFR levels at admission and mortality in patients with intracerebral hemorrhage. Patients with intracerebral hemorrhage and eGFR levels <15 ml/min/1.73 m2 have a near 4-fold increased hazard of deaths compared to those with intracerebral hemorrhage and eGFR levels ≥ 90 mL/min/1.73m2. The eGFR level could be used as an early biomarker to identify high mortality risks for patients with intracerebral hemorrhage. Patients with intracerebral hemorrhage and a low eGFR deserve more clinical attention and closer follow-up monitoring.